Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA DR. REDDYS LAB NATCO PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 13.3 19.7 67.7% View Chart
P/BV x 3.5 4.4 78.8% View Chart
Dividend Yield % 0.6 0.6 88.9%  

Financials

 NATCO PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
DR. REDDYS LAB
Mar-23
NATCO PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs8474,656 18.2%   
Low Rs5023,788 13.3%   
Sales per share (Unadj.) Rs148.41,481.4 10.0%  
Earnings per share (Unadj.) Rs39.2270.7 14.5%  
Cash flow per share (Unadj.) Rs48.2345.7 13.9%  
Dividends per share (Unadj.) Rs5.5040.00 13.8%  
Avg Dividend yield %0.80.9 86.1%  
Book value per share (Unadj.) Rs267.11,389.6 19.2%  
Shares outstanding (eoy) m182.47166.53 109.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.52.8 159.5%   
Avg P/E ratio x17.215.6 110.3%  
P/CF ratio (eoy) x14.012.2 114.6%  
Price / Book Value ratio x2.53.0 83.1%  
Dividend payout %14.014.8 94.9%   
Avg Mkt Cap Rs m123,049703,039 17.5%   
No. of employees `000NANA-   
Total wages/salary Rs m4,86746,466 10.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,071246,697 11.0%  
Other income Rs m1,28510,555 12.2%   
Total revenues Rs m28,356257,252 11.0%   
Gross profit Rs m9,11763,860 14.3%  
Depreciation Rs m1,63812,502 13.1%   
Interest Rs m1451,428 10.2%   
Profit before tax Rs m8,61960,485 14.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,46615,412 9.5%   
Profit after tax Rs m7,15345,073 15.9%  
Gross profit margin %33.725.9 130.1%  
Effective tax rate %17.025.5 66.8%   
Net profit margin %26.418.3 144.6%  
BALANCE SHEET DATA
Current assets Rs m30,003203,161 14.8%   
Current liabilities Rs m6,83185,721 8.0%   
Net working cap to sales %85.647.6 179.8%  
Current ratio x4.42.4 185.3%  
Inventory Days Days6379 80.1%  
Debtors Days Days115107 107.6%  
Net fixed assets Rs m26,571112,638 23.6%   
Share capital Rs m365833 43.8%   
"Free" reserves Rs m48,373230,571 21.0%   
Net worth Rs m48,738231,404 21.1%   
Long term debt Rs m01,278 0.0%   
Total assets Rs m56,574315,799 17.9%  
Interest coverage x60.443.4 139.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.8 61.3%   
Return on assets %12.914.7 87.6%  
Return on equity %14.719.5 75.3%  
Return on capital %18.026.6 67.6%  
Exports to sales %052.2 0.0%   
Imports to sales %10.216.8 60.9%   
Exports (fob) Rs mNA128,803 0.0%   
Imports (cif) Rs m2,77241,484 6.7%   
Fx inflow Rs m17,256128,803 13.4%   
Fx outflow Rs m2,77241,484 6.7%   
Net fx Rs m14,48487,319 16.6%   
CASH FLOW
From Operations Rs m8,49158,875 14.4%  
From Investments Rs m-4,771-41,373 11.5%  
From Financial Activity Rs m-3,630-26,861 13.5%  
Net Cashflow Rs m208-9,073 -2.3%  

Share Holding

Indian Promoters % 49.7 26.7 186.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 47.3 52.8%  
FIIs % 13.7 28.6 47.9%  
ADR/GDR % 0.0 15.3 -  
Free float % 50.3 58.0 86.7%  
Shareholders   207,571 257,794 80.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Natco Pharma vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Dr. Reddys Share Price Performance

Period Natco Pharma Dr. Reddys S&P BSE HEALTHCARE
1-Day -2.11% 1.78% 1.18%
1-Month -3.19% -4.23% -0.75%
1-Year 72.80% 35.93% 61.82%
3-Year CAGR 4.96% 10.85% 18.16%
5-Year CAGR 10.96% 17.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Dr. Reddys paid Rs 40.0, and its dividend payout ratio stood at 14.8%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.